___

• Ahrendt, D. (2001). Ergogenic Aids: Counseling the Athlete. Am Fam Physician, 63,913-22.
• Alba-Roth, J., Muller, O.A., Schopohl, J. & Von Werder, K. (1998). Arginine stimulates growth hormone secretion by suppressing endogenous soma- tostatin secretion. J Clin Endocrinol Metab, 67(6), 1186-9.
• Anderson, S. & Raiten, D. (1992). Safety of amino acids used as dietary supp- lements: Life Sciences Research Office, FDA Contract No. 223-88- 2124.117-125.
• Balon, T. & Nadler, J. (1994). Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol, 77, 2519-21.
• Balon, T. & Nadler, J. (1997). Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol, 82, 359-363.
• Barbul, A. (1986). "Arginine: Biochemistry, physiologY, and therapeutic implications." J Parenter Enteral Nutr, 10(2), 227-38.
• Bednarz, B., Jaxa-Chamiec, T., Gebalska, J., Herbaczynska-Cedro, K. & Ceremuzynski, L. (2004). L-arginine supplementation prolongs duration of exercise in congestive heart failu- re. Pol HeartJ, 60(4), 348-53.
• Bednarz,B.,Jaxa-Chamiec,T., Maciejewski, P., Szpajer, M., Janik, K., Gniot, J., Kawka-Urbanek,T. Drozdowska, D. Gessek, J. & Laskowski, H. (2005). Efficacy and safety of oral L-arginine in acute myo- cardial infarction. Results of multi- center randomized,doub|e- blind, p- lacebo-controlled ARAMI pilot trial. Kardiol Pol, 62,421-6
• Boger, R.H. & Bode-Boger, S.M. (2001). The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol, 41,79-99.
• Bucci, L. (1993). Nutrients as Ergogenic Aids for Sports and Exercise. Wolinsky, |. & Hickson, J.F (eds). Nutrition and the Strength Athlete, Boca Raton, CRC Press.
• Buford, B.N. & Koch, A.J. (2004) Glycine- arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Med Sci Sports Exerc, 36. 583-587.
• Burtscher, M., Brunner, F., Fathaber, M., Hotter, B. & Rudolf, L. (2005). The prolonged intake of L-arginine L- aspartate reduces blood lactate ac- cumulation and oxygen consumption during submaximal exercise. J Sport Sci Med,4,314-322.
• Campbell, B., La Bounty, P. & Roberts, M. (2004). The Ergogenic Potential ofAr- ginine.JlntSocSport Nut, 1(2),35- 38.
• Campbell, B., Roberts, M., B.S., Kerksick, C.& WiIborn, C. (2006). Pharmaco- kinetics, safety, and effects on exer- cise performance of L-arginine alfa- ketoglutarate in trained adult men. Nutrition,22 ,872-881.
• Ceremuzynski,L. Chamiec,T. & Herbacynska-Cedro, K.(1997). Effect on supplemental oral L-arginine exer- cise capacity in patients with stable angina pectoris. Am J Cardiol, 80, 331-33.
• Champe, P.C. & Harvey, R.A. (1994). Biochemistry, J.B. Lippincott Company: Philadelphia, Chen, J., Wollman, Y., Chernichovsky,T., Iaina, A., Sofer, M. & Matzkin, H. (1999). Effect of oral administration of high- dose nitric oxide donor L-arginine in men with organic erectile dysfunc- tion: results of a double-blind, randomized, placebo-controlled study. BJU Int, 83(3), 269-73.
• Cheng, J.W. & Balwin, SN. (2001). L- arginine in the management of car- diovascular diseases. Ann Pharma- cother, 35, 755-64.
• Colombani, P.C., Bitzi, R., Frey-Rindova, P., Frey, W., Arnold,M., Langhans, W. & Wenk, C. (1999). Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run. EurJ Nutr, 38,263-70.
• Cooke, J.P.&Tsao, P.S. (1997). Arginine: A new therapy for atherosclerosis? Circulation,95,311-312.
• Creager, M.A., Gallagher, S.J., Girerd, X.J., Coleman, S.M., Dzau, V.J. & Cooke, J.P. (1992). L-arginine im- proves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest, 90,1248-53.
• Doutreleau, S., Mettauer, B., Piquard, F., Schaefer,A., Lonsdorfer,E., Richard, R. & Geny, B. (2005). Chronic but not acute oral L-arginine supplementati- on delays the ventilatory threshold during exercise in heart failure pati- ents. Can J Appl Physiol,30(4),419- 432.
• Doutreleau, S., Mettauer, B., Piquard, F., Rouyer, O., Schaefer, A., Lonsdorfer, J. & Geny, B. (2006). Chronic L- argi- nine supplementation enhances en- durance exercise tolerance in heart failure patients. Int J Sports Med, 27(7),567—72.
• Esplugues, J.V. (2002). NO as a signalling molecule in the nervous system. BritJ Pharmacol, 135, 1079- 1095.
• Fisker, S., Nielsen, S., Ebdrup, L., Bech, J.N., Christiansen, J.S., Pedersen, E.B. & Jorgensen, J.O. (1999a). The role of nitric oxide in L-arginine stimu- lated growth hormone release. J En- docrinollnvest, 22, 89-93.
• Fisker, S., Nielsen, S., Ebdrup, L., Bech, J.N., Christiansen, J.S., Pedersen, E. B. & Jorgensen, J.O. (1999 b). L-argi
• nine-induced growth hormone sec- retion is not inşuenced by coinfusion of the nitric oxide synthase inhibitor N-monomethyI-L-arginine in healthy men. Growth Horm IGF Res 9, 69-73.
• F|ako||,P.,Sharp,R.,Baier,S.,Levenhagen, D., Carr, C. & Nissen,S.(2004). Effect of beta-hyd roxy-betamethylbutyrate, arginine, and Iysine supplementation on strength, functionality, body com- position, and protein metabolism in- elderly women. Nutrition, 20,445-51.
• Giugliano, D., Marfella, R., Verrazzo, G., Acampora,R.,Coppola,L.&Cozzolino D.(1997). The vascular effects of L- arginine in humans. J Clin lnvest,99, 433-438.
• Green, S.J., Mellouk,S. & Hoffman, S.L. (1990).Cellular mechanisms of non- speciŞc immunity to intracellular in- fection: cytokine induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. lmmunolLett,25(1-3),15-9.
• Gremion,G., Palud,P. &Gobelet,C. (1989). Arginine aspartate and muscular acti- vity. Partll. SchweizerZeitschrift fiir Sportmedizin, 37, 241-246.
• Hurson, M., Regan M.C., Kirk, S.J., Wasserkrug, H.L. & Barbul, A. (1995). Metabolic effects of arginine in a healthy elderly population. J parenter Enteral Nutr, 19(3), 227-30.
• Huynh, N.T. & Tayek, J.A. (2002). Oral arginine reduces systemic blood pressure in type 2 diabetes: lts po- tential role in nitric oxide generation. J Am Coll Nutri, 21 (5),422-7.
• lsidori,A., Monaco A.L. & Cappa, M. (1981). A study of growth hormone release in man after oral administra- tion of amino acids. Curr Med Re- search and Opinion, 7(7), 475 -481.
• Juhn, M.S. & Tarnopolsky, M. (1998). Oral creatine supplementation and athle- tic performance:Acritical review. Clin J Sport Med, 8, 286 -297.
• Kindig, C.A., McDonough, P., Erickson, H. H. & Poole, D.C. (2001). Effect of L- NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse. JAppl Physiol, 91,891-96.
• Kirk, S.J, Hurson, M., Regan, M.C., Holt, D.R., Wasserkrug, H.L. & Barbul, A. (1993).Arginine stimulates wound he- aling and immunefunction in elderly human beings. Surgery,114(2),155-9.
• Lambert, M.I., Hefer, J.A., Millar, R.P. & Macfarlane, P.W. (1993). Failure of commercial oral amino acid supple- ments to increase serum growth hor- mone concentrations in male body- builders. lntJ Sport Nutr,3,298—305.
• Lawrence, M., & Kirby, D. (2002). Nutrition and sports supplements: Fact or Şction. J Clin Gastro, 35, 299-306.
• Lin, W.T., Yang, S.C., Tsai, S.C., Huang, C.C. & Lee, N.Y. (2006). L-Arginine attenuates xanthine oxidase and m- yeloperoxidase activities in hearts of rats during exhaustive exercise. Brit J Nut, 95(1), 67-75.
• Maccario, M., Procopio, M., Loche, S., Cappa, M., Martina, V., Camanni, F. & Ghigo, E. (1994). Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabo- Iism, 43, 223-226.
• Marcell, T.J., Taaffe, D.R., Hawkins, S.A., Tarpenning, K.M., Pyka, G., Kohlmeier,L., Wiswell,R.A.& Marcus, R.(1999). Oral arginine does not sti- mulate basal or augment exercise - induced GH secretion in either young or old adults. J Gerontol A Biol Sci Med Sci, 54, 395-399.
• MaxweII,A.J., Ho, H.V., Le, C.Q., Lin, P.S., Bernstein,D. & Cooke, J.P.(2001). L- arginine enhances aerobic exercise capacity in association with augmen- ted nitric oxide production. J Appl Physiol,90, 933-938.
• Merimee, T.J., Rabinowitz, D., Riggs, L., Burgess, J.A., Rimoin, D. L. & Mc Kusick, V.A. (1967). Plasma g rowth hormone after arginine infusion. Cli- nicalexperiences.N Engl J M e d , 276, 434 - 439.
• Merimee, T.J., Rabinowitz, D. & Fineberg, S.E. (1969).Arginine-initiated release of human growth hormone:factors modifying the response in normal man. N Engl J Med, 280,1434—1438.
• Mills, P.C., Marlin, D.J., Scott, C.M. & Smith, NO. (1999). Metabolic effects of nitric oxide synthase inhibition dur- ing exercise in the horse. Res Vet Sci, 66,135-138.
• Mohr, S., Stamler, J.S. & Brune, B. (1996). Posttranslational modiŞcation of gly- ceraldehyde- 3 -phosphate dehydro- genase by S-nitrosylation and sub- sequent NADH attachment. J Biol Chem,271, 4209-4214.
• Morris, C. R., Morris, S.M., Hagar, W., Van Warmerdam J., Claster, S., Kepka - Lenhart, D., Machado, L., Kuypers,F. A. & Vichinsky, E.P. (2003). Arginine therapy: A new therapy for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med, 168(1), 63-69.
• Mühling, J., Fuchs, M., Fleck, C., Sablotzki,A., KrüII, M., Dehne, M.G., Gonter, J., Weiss, S., Engel, J. & Hempelmann, G. (2002). Effects of arginine, L- alanyl L-glutamine ortau- rine on neutrophil (PMN) free amino acid profiles and immune functions in vitro. AminoAcids, 22(1),39-53.
• Nagaya, N., Uematsu, M., Oya, H., Sato N, Sakamaki, F., Kyotani, S., Ueno, K., Nakanishi, N., Ymagishi, M. & Miyatake, K. (2001). Short-term oral administration of L-arginine improves hemodynamics and exercise capa- cityin patients with precapillary pul- monary hypertension. Am J Res-pir Crit Care Med, 163, 887-91.
• Nielsen, H.B., Clemmesen, J.O., Skak, C., Ott, P. & Scher, N.H. (2002). Attenu- ated hepatosplanchnic uptake of lac- tate during intense exercise in hu- mans. J Appl Physiol, 92(4),1677- 1683.
• Oomen, C.M., van Erk, M.J., Feskens, E.J., Kok, F.J. & Kromhout, D. (2000). Arginine intake and riskof co ro na ry heart disease mortality in elderly men.ArterioscIer Thromb V a s c Biol,20(9), 2134-2139.
• Paddon-Jones, D., Borsheim, E. & Wolfe, R.R.(2004). Potential ergogenic ef- fects of arginine and creatine supp- Iementation.J Nutr, 134,28888 2894S.
• Palmer, J.P., Walter, R.M. & Ensinck, J.W. (1975). Arginine-stimulated acute phase of insulin and glucagon sec- retion. l. in normal man. Diabetes, 24,735-740.
• Palmer, R.M., Ferrige,A.G. & Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327(6122), 524 - 526.
• Reid, MB. (1998). Role of nitric oxide in skeletal muscle: synthesis, distri- bution and functional importance. Acta Physiol Scan, 162, 401-409.
• Reiser, P.J., Kline, W.O. & Vaghy, P.L. (1997). Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimu- Iation in vivo. J Appl Physiol, 82, 1250-1255
• Saitoh, S., & Suzuki, M. (1986). Nutritional design for repletion of liver and muscle glycogen during endurance exercise without inhibiting lipolysis. J Nutr Sci Vitaminol, 32, 343 - 353.
• Sales, R.P., César Miné, C.E., Franco, A. D. & Rodrigues, EL. (2005). Effects of the acute arginine aspartate supp- lement on the muscular fatigue in trained volunteers, Rev Bras Med Esporte, 11(6), 347-351.
• Santos, R.S., Pacheco, M.T., Martins, R., ViIIaverde, A.B., Giana, H.E., Baptista, F. & Zangaro, R.A. (2002). Study of the effect of oral adminis- tration of L-arginine on muscular per- formance in healthy volunteers: an isokinetic study. Isokinet Exerc Sci, 10,153-8.
• Schaefer, A., Piquard, F., Geny, B., Doutreleau, S., Lampert, E., Mettauer, B. & Lonsdorfer, J. (2002). L-Arginine reduces exercise-induced increase in plasma lactate and am- monia. IntJ Sports Med, 23, 403—407.
• Stamler, J.S. & Meissner, G. (2001). Phy- sio|ogy of nitric oxide in skeletal muscle. Physiol Rev, 81(1), 209-237.
• Stead, L.M., Au, K.P., Jacobs, R.L., Brosnan, M.E. & Brosnan, J.T.(2001). Methylation demand and homo- cysteine metabolism: effects of die- tary provision of creatine and guanidi- neacetate. Am J Physiol, 281,E1095 -E1100.
• Suminski, R.R. (1997). Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentrations in young men. Int J Sport Nutr, 7(1), 48-60.
• Swanson, B., Keithley, J.K., Zeller, J.M. & Sha, B.E. (2002). A pilot study of the safety and efŞcacy of supplemental arginineto enhance immune functi- on in persons with HIV/AIDS. Nutrition, 18(7—8), 688-690.
• Tachibana, K., Mukai, K. Hiraoka, I., Moriguchi, S., Takama, S. & Kishino, Y. (1985). Evaluation of the effect of arginine-enriched amino acid solu- tion on tumor growth. J Parenter Enteral Nutr, 9(4), 428-434.
• Thomas, G.D. & Victor, R.G. (1998). Nitric oxide mediates contraction- induced attenuation of sympathetic vaso- constriction in rat skeletal muscle. J Physiol, 506, 817- 826.
• Tong, B.& Barbul, A. (2004). Cellular and Physiological Effects of Arginine. Mini-Rev Med Chem, 4, 823-832.
• Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L. & Hespel, P. (1997). Long-term crea- tine intake is beneficial to muscle performance and pharmacokinetic considerations. J Appl Physiol, 83, 2055-2063.
• Van Haeften, T.W., Voetberg, G.A., Gerich, J.E. & van der Veen, EA. (1989). Dose response charac- teristics for arginine-stimulated insulin secretion in man and inşuence of hyperglycemia. J Clin Endocrinol Metab, 69,1059-64.
• Visek, W.J. (1986). Arginine needs phy- siological state and usual diets: A reevaluation. J Nutr, 116, 36-46.
• Volek J.S., Duncan N.D., Mazzetti S. A. & Putukian M.(1999). Performance and muscle Şber adaptations to creatine supplementation and heavy resistan- ce training. Med Sci Sports Exerc, 31,1147-1156.
• Volpi, E., Kobayashi, H., ShefŞeld-Moore, M., Mittendorfer, B. & Wolfe, R.R. (2003) Essential amino acids stimu- latemuscleprotein anabolism in healthy older adults regardless of the presence of non-essential amino a- cids. Am J Clin Nutr, 78, 250-258.
• Walberg-Rankin, J., Hawkins, C., Fild, D. & Sebolt, D. (1994). The effect of oral
• arginine during energy restriction in male weight trainers. J Strength Cond Res, 8(3), 170-177.
• Walker, J.B. (1979). Creatine:biosynthe- sis, regulation, and function. Adv Enzymol Relat Areas Mol Biol, 50, 177-242.
• Weidenbach, H., Nussler, A.K., Shu, Z., Adler, G. & Beckh, K. (1997). Nitric oxide formation lowers norepine- phrine-induced intrahepatic resistan- cewithout major effects on the me- tabolism in the perfused rat liver. Hepatology, 26(1), 147-54.
• Wells, B.J., Mainous, A.G. & Everett, C.J. (2005) Association between dietary arginine and C-reactive protein. Nut- rition,121(2),125-130.
• Wolin, M.S., Hintze, T.H., Shen, W., Mohazzab-H, K.M.& Xie,Y.W. (1997). Involvement of reactive oxygen and nitrogenspeciesin signaling mec- hanisms that control tissue respira- tion in muscle. Biochemical So- ciety Transactions, 25(3), 934-39.
• Wolinsky, I. & Hickson, J.F. (1998). Nutrition in Exercise and Sport, Second Edition. Nutrition and the StrengthAthlete,
• Wolinsky I. & Hickson J. F.. Boca Raton, CRC Press. Wu, G. & Morris, S.M. (1998). Arginine metabolism: Nitric oxide and beyond. Biochem J, 336(1 ), 1-17.